Cadre Holdings Achieves Analyst Price Target
Current Stock Performance: Cadre Holdings Inc (CDRE) shares have surpassed the average analyst 12-month target price of $41.83, trading at $42.60/share, prompting potential analyst reactions regarding valuation adjustments.
Analyst Target Range: There are six different analyst targets for CDRE, with estimates ranging from a low of $26.00 to a high of $50.00, indicating a standard deviation of $8.158 among the analysts' predictions.
Investor Considerations: The crossing of the average target price signals investors to evaluate whether the stock is on a trajectory for further gains or if it has become overvalued, suggesting a reassessment of their positions.
Analyst Ratings Overview: The article references a rating scale from 1 (Strong Buy) to 5 (Strong Sell) for CDRE, reflecting the collective insights of analysts covering the stock, as provided by Zacks Investment Research.
Trade with 70% Backtested Accuracy
Analyst Views on CDRE
About CDRE
About the author
Cadre Holdings (CDRE) Increases Quarterly Dividend by 5.3% to $0.10 per Share
- Dividend Increase: Cadre Holdings raised its quarterly dividend from $0.095 to $0.10 per share, marking a 5.3% increase that reflects the company's ongoing improvement in cash flow and profitability, which is expected to boost investor confidence.
- Dividend Payment Schedule: The new dividend will be payable on February 13, with a record date of January 30 and an ex-dividend date also on January 30, ensuring that existing shareholders receive timely returns, thereby strengthening the shareholder base.
- Sales Target: Cadre Holdings has set a sales target of $624 million to $630 million for 2025, indicating the company's optimistic outlook for future performance while actively advancing the acquisition of TYR Tactical to achieve this goal.
- Contract Win: A subsidiary of Cadre Holdings secured a $50 million contract with the Department of Defense, which not only provides a significant revenue stream but also enhances the company's market position in the defense sector.
Cadre Holdings Subsidiary Secures $50 Million Contract with the Department of Defense
Contract Award: Cadre Holdings' subsidiary, Med-Eng, has secured a 5-year contract worth up to $50 million from the U.S. Department of War to provide a Blast Exposure Monitoring (BEMO) system aimed at enhancing warfighter safety during training operations.
Technological Innovation: The BEMO system will utilize advanced sensor hardware and software to monitor and record blast overpressure exposures, contributing to the DoW's Brain Health program and enabling real-time updates for military personnel.
Future Deliveries: The first deliveries under this contract are expected to begin in 2026, following a competitive development program focused on improving identification methods for blast overpressure exposures in combat and training environments.
Company Background: Cadre Holdings, based in Jacksonville, Florida, specializes in safety equipment for various sectors, including law enforcement and military, with a commitment to innovation and user safety through its products.
